Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prognostic Value of Biomarker in Connective Tissue Disease Patients With Pulmonary Hypertension

NCT05980728 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.

NCT NCT05980728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05980728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prognostic Value of Biomarker in Connective Tissue Disease Patients With Pulmonary Hypertension
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University
Phase
Observational
Overall status
Not yet recruiting
Start date
November 1, 2023
Completion date
September 1, 2030
Enrollment
500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

connective tissue diseases, pulmonary hypertension